endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Startups channel feed

Dutch rare dis­ease biotech Pro­QR carves out new com­pa­ny ded­i­cat­ed to epi­der­mol­y­sis bul­losa

7 years ago

Biotech’s new­born uni­corn Sana grabs Har­vard tech aimed at slip­ping en­gi­neered stem cells past the im­mune sys­tem

7 years ago

Bone-mar­row fo­cused Ima­go Bio­Sciences scores $40M in Omega-led round

7 years ago
Financing

Feng Zhang, heavy­weight col­lab­o­ra­tors un­veil lat­est CRISPR up­start — a di­ag­nos­tic com­pa­ny

7 years ago

Arch-backed biotech hauls in a fast B round as its re­born an­ti-psy­chot­ic zooms to a PhII fin­ish line

7 years ago
Financing

Sur­rozen banks $50M round to fu­el its dri­ve to the clin­ic with re­gen­er­a­tive med plat­form

7 years ago
Financing

Deer­field takes trans­la­tion­al part­ner­ship mod­el to Har­vard with $100M deal

7 years ago
R&D

Lund­beck fund backs a $50M launch round for SNIPR Bio­me, a new brand of CRISPR Cas biotech

7 years ago
Financing

Look­ing to cap­i­tal­ize on ge­net­ic mod­i­fiers, Maze Ther­a­peu­tics launch­es with $191M in fi­nanc­ing led by Arch, Third Rock

7 years ago
Financing

Black­stone antes $250M on its first big biotech bet, fo­cused on a car­dio drug spun out of No­var­tis

7 years ago
Financing

Serono spin­off Ca­lyp­so Biotech be­comes res­i­dent at J&J's Eu­ro­pean in­cu­ba­tor, rais­es $22M+ in Se­ries A

7 years ago
Financing

Backed by Or­biMed and J&J to build pre­ci­sion bac­te­ria-killing tool, Bio­mX adds a slate of in­vestors in $32M Se­ries B

7 years ago
Financing

James Wil­son turns to old men­tor for gene ther­a­py star­tup's star-stud­ded $115M launch round

7 years ago
Financing

Ra­maswamy's Ax­o­vant whips up a CNS spin­off with a $530M deal and a syn­di­cate of sup­port­ers

7 years ago
Pharma

David de Graaf has a new gig, a new idea and a new start­up — hunt­ing some new mon­ey

7 years ago
People

Af­ter a short stint at In­ter­cept, Rachel McMinn makes the leap from biotech an­a­lyst to biotech CEO

7 years ago
People
Financing

So­lid­i­fy­ing a new cor­po­rate struc­ture, IFM launch­es sec­ond unit fo­cused on cGAS-STING

7 years ago

Canaan leaps in­to UK biotech by co-lead­ing $14M Se­ries A for im­muno-on­col­o­gy up­start Grey Wolf

7 years ago
Financing

Rut­gers sci­en­tists form im­muno-on­col­o­gy biotech to de­vel­op pipeline of TAM in­hibitors

7 years ago

Arch joins Cel­gene, Chi­na in­vestors bankrolling a pi­o­neer­ing New York biotech start­up fo­cused on a new ap­proach to metas­ta­sis

7 years ago
Financing

Ke­to in a pill? Jim Mel­lon de­buts an­ti-ag­ing joint ven­ture with the Buck ded­i­cat­ed to in­duc­ing ke­to­sis

7 years ago

Medicxi bankrolls the launch of a pair of biotech twins fo­cused on orex­ins for nar­colep­sy and more

7 years ago
Financing

Po­laris’ Amir Nashat pulls to­geth­er a $60M launch round to back the birth of a new biotech build­ing a drug de­vel­op­ment plat­form from scratch

7 years ago
Financing

The next 5 years: High­er R&D pro­duc­tiv­i­ty is here to stay, emerg­ing biotechs and new tech will have a big im­pact. But what about pric­ing?

7 years ago
R&D
Pharma
First page Previous page 59606162636465 Next page Last page
A service from the Financial Times